Immunohistochemical study of fibronectin for postmortem diagnosis of early myocardial infarction

B J Hu1, Y C Chen, J Z Zhu

  • 1Department of Forensic Pathology, Sun Yat-sen University of Medical Sciences, Guangzhou, China.

Insights

Forensic diagnosis of early myocardial infarction is challenging. Fibronectin (FN) staining in cardiomyocytes is a reliable new marker for detecting acute myocardial infarction, even in autopsied hearts fixed for years.

Area of Science:

  • Forensic Pathology
  • Cardiovascular Pathology
  • Immunohistochemistry

Background:

  • Diagnosing early myocardial infarction postmortem presents significant forensic challenges.
  • Current methods may lack sensitivity or be affected by postmortem changes.
  • A reliable biomarker for early detection is crucial in forensic practice.

Purpose of the Study:

  • To evaluate fibronectin (FN) immunohistochemistry as a novel method for diagnosing early myocardial infarction in autopsy cases.
  • To determine the reliability of FN staining in cardiomyocytes for postmortem identification of acute myocardial infarction.

Main Methods:

  • An immunohistochemical study using the streptavidin/biotin/peroxidase technique was performed on 34 autopsy hearts.
  • Fibronectin (FN) staining was assessed in cardiomyocytes of cases with confirmed myocardial infarction, suspected early infarction, and controls.
  • Cases included those autopsied between 8 hours and 4 days postmortem, with some fixed in formalin for over 10 years.

Main Results:

  • Positive FN staining in cardiomyocytes was observed in all 5 definite myocardial infarction cases.
  • 15 out of 18 suspected early myocardial infarction cases showed positive FN staining.
  • No positive FN staining was detected in 11 non-cardiac death control cases.
  • Satisfactory FN staining results were obtained even in cases fixed for over 10 years, indicating resistance to autolysis and formalin fixation.

Conclusions:

  • Positive fibronectin (FN) staining in cardiomyocytes is a reliable and sensitive marker for the postmortem diagnosis of acute myocardial infarction.
  • FN immunohistochemistry offers a valuable new method for routine forensic practice, particularly for retrospective analysis.
  • Fibronectin's stability against postmortem autolysis and formalin fixation makes it suitable for long-term archival cases.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...